PELLEGRINO, Michele
 Distribuzione geografica
Continente #
NA - Nord America 2.181
EU - Europa 1.523
AS - Asia 750
AF - Africa 49
SA - Sud America 36
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.550
Nazione #
US - Stati Uniti d'America 2.117
UA - Ucraina 425
DE - Germania 283
SG - Singapore 270
AT - Austria 266
CN - Cina 235
IT - Italia 218
SE - Svezia 120
HK - Hong Kong 87
FR - Francia 61
CA - Canada 58
TR - Turchia 56
IN - India 54
FI - Finlandia 49
SN - Senegal 44
BR - Brasile 29
GB - Regno Unito 26
BE - Belgio 18
CZ - Repubblica Ceca 16
KR - Corea 13
NL - Olanda 8
IR - Iran 7
AU - Australia 6
ID - Indonesia 6
PK - Pakistan 6
CH - Svizzera 4
EU - Europa 4
MX - Messico 4
RU - Federazione Russa 4
EC - Ecuador 3
LT - Lituania 3
PT - Portogallo 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
EG - Egitto 2
IE - Irlanda 2
MK - Macedonia 2
PE - Perù 2
PL - Polonia 2
RO - Romania 2
RS - Serbia 2
VN - Vietnam 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
LV - Lettonia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
Totale 4.550
Città #
Chandler 355
Jacksonville 247
Boardman 187
Singapore 179
Vienna 176
San Mateo 166
Dearborn 133
New York 105
Ashburn 76
Shanghai 64
Lawrence 62
Roxbury 61
Izmir 48
Helsinki 47
Rende 45
Dakar 44
Des Moines 44
Ottawa 43
Brooklyn 36
Ann Arbor 35
Beijing 35
Grafing 32
Bremen 31
Hong Kong 27
Wilmington 24
Redwood City 20
Inglewood 19
Brussels 18
Seattle 18
Cambridge 16
Florence 16
Ogden 16
Falls Church 15
Pune 15
Seoul 13
Brno 12
Catanzaro 12
Toronto 12
Wuhan 9
Guangzhou 8
San Francisco 8
Cosenza 7
Los Angeles 7
Munich 7
Wuxi 7
Chennai 6
Falkenstein 6
Rome 6
Faisalabad 5
Houston 5
Nanjing 5
Augusta 4
Bari 4
Feroleto della Chiesa 4
Hanover 4
Jiaxing 4
Lamezia Terme 4
London 4
Milan 4
Mumbai 4
Olomouc 4
Quanzhou 4
Sittard 4
Amantea 3
Ardabil 3
Belvedere Marittimo 3
Bengaluru 3
Berlin 3
Canberra 3
Jakarta 3
Jinhua 3
Kilburn 3
Melbourne 3
Monmouth Junction 3
New Delhi 3
Newark 3
Quito 3
Shenyang 3
Shenzhen 3
Tashkent 3
Baku 2
Bandung 2
Belgrade 2
Belo Horizonte 2
Birmingham 2
Bornova 2
Brasília 2
Cairo 2
Cappelle sul Tavo 2
Castrolibero 2
Castrovillari 2
Crotone 2
Dalian 2
Dublin 2
Edinburgh 2
Frankfurt am Main 2
Geneve 2
Groningen 2
Hangzhou 2
Hefei 2
Totale 2.729
Nome #
3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression 143
Transferrin-conjugated pluronic niosomes as a new drug delivery sistem for anticancer therapy 127
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression 126
Bortezomib-loaded mesoporous silica nanoparticles selectively alter metabolism and induce death in multiple myeloma cells 121
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells 118
A xenograft model highlights the dichotomic effects induced by adiponectin on cyclin D1 in human breast cancer cells accordingly to ERα expression. 116
Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy 108
Estrogenic GPER signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (CAFs) 106
E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor 104
Anticancer activity of a hydrogel containing folic acid towards MCF-7 and MDA-MB-231 cells 103
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ER. 2nd Joint Meeting of Pathology and Laboratory Diagnostics, 2014 September 17-20, Palermo, Italy. Am J Pathol ,184(Suppl):S34 Abstract MTP1, 2014. Oral communication 101
Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer 99
Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination 95
Cachrys spp. from Southern Italy: Phytochemical Characterization and JAK/STAT Signaling Pathway Inhibition 88
Dealing with skin and blood-brain barriers: The unconventional challenges of mesoporous silica nanoparticles 87
Effects of Adiponectin on Cyclin D1 Expression in Breast Cancer Cells are Dependent on ERα 86
Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells 86
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 82
GPER mediates activation of HIF1α/VEGF signaling by estrogens 78
Evidence that low doses of taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells 78
Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor 78
Chitosan membranes filled with cyclosporine a as possible devices for local administration of drugs in the treatment of breast cancer 76
Evidences that leptin upregulates E-cadherin expression in breast cancer and promotes tumor cell growth and progression 75
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts 75
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 73
Evidences that Estrogen Receptor alpha interferes with adiponectin effects on breast cancer cell growth 72
Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism 70
GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer 70
FoxO3a mediates the inhibitory effects of the antiepileptic drug Lamotrigine on breast cancer growth 69
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies. 69
Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells 68
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 67
In vivo and in vitro evidence that PPARγ ligands are antagonists of leptin signaling in breast cancer. 62
Diarylureas: Repositioning from Antitumor to Antimicrobials or Multi-Target Agents against New Pandemics 61
Evidences that leptin upregulates E-cadherin expression in breast cancer: effects on tumor growth and progression 60
Tamoxifen and epidermal growth factor induce the aggregation of MCF7 breast cancer cells up-regulating E-cadherin expression 56
Production of Plant-Derived Oleuropein Aglycone by a Combined Membrane Process and Evaluation of Its Breast Anticancer Properties 55
Foxo3a inhibits tamoxifen-resistant breast cancer progression by inducing integrin α5 expression 55
Fas ligand in TM4 cells is up-regulated by estradiol through Estrogen Receptor alpha interaction with Sp-1 53
Molecular mechanism through which leptin upregulates e-cadherin expression and influences breast cancer cell growth and progression 52
The antiepileptic drug Lamotrigine, through FoxO3a, inhibits breast cancer growth and development both in vitro and in vivo. Pellegrino M, Rizza P, Giordano F, Spina E, Ceraldi R, Andò S, Morelli C, Sisci D. 51
PI3-kinase/Akt pathway is involved in the short non genomic autocrine loop between 17-β estradiol and aromatase activity in MCF-7 cells. 50
The modulatory role of IRS-1 on cell adhesion in human breast cancer cells 49
Fas ligand expression in TM4 sertoli cells is enhanced by estradiol "in situ" production 48
Evidences that leptin upregulates E-cadherin expression in breast cancer: effects on tumor growth and progression 48
PPARγ ligand rosiglitazone counteracts the stimulatory effectsof leptin on breast cancer growth 47
PI3-kinase/Akt pathway is involved in the short non genomic autocrine loop between 17-beta estradiol and aromatase activity in MCF-7 cells 47
Biocompatible targeting hydrogels for breast cancer treatment 45
PPAR-gamma ligand rosiglitazone counteracts the stimulatory effect of leptin on breast cancer growth 45
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway 43
PPARγ ligands as antagonists of leptin signaling in breast cancer: in vivo and in vitro effects 43
Peroxisome proliferator-activated receptor (PPAR)gamma is expressed by human spermatozoa: its potential role on the sperm physiology 42
Inhibitory effect of adiponectin on breast cancer cell growth: evidences of the crucial role of ER{alpha} expression 41
Taxol activates p21 waf promoter, via p53, in MCF-7 breast cance cells 41
PPARgamma ligands as antagonists of leptin signaling in breast cancer: in vivo and in vitro effects 40
First evidences that Resveratrol through p53/Sin3/HDAC1 complex phosphorylation inhibits ESR1 gene expression via p38MAPK signalling.expression via p38MAPK/CK2 signalling in human breast cancer cells 40
PPAR gama ligand rosiglitazone counteracts the stimmulatory effect of leptin on breast cancer growth 39
Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism. (corresponding author) 38
Resveratrol through p53/Sin3/HDAC1 complex phosphorylation inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signalling in human breast cancer cells 38
Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages 38
The pMAPK/pAMPK ratio modulates the effect of adiponectin on breast cancer cell growth 37
Molecular mechanism trough which leptin upregulates E-cadherin expression in breast cancer. In vitro and in vivo effects on tumor cell growth and progression. 35
Role of ER-α in the modulatory effect of adiponectin on breast cancer cell growth 31
N-Heterocyclic Carbene-Gold(I) Complexes Targeting Actin Polymerization 31
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 27
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic. 26
Application of Natural Edible Coating to Enhance the Shelf Life of Red Fruits and their bioactive content 25
Triclosan: A Small Molecule with Controversial Roles 23
N-Heterocyclic Carbene (NHC) Silver Complexes as Versatile Chemotherapeutic Agents Targeting Human Topoisomerases and Actin 21
Identification of Pinosylvin in Pinus nigra subsp. laricio: A Naturally Occurring Stilbenoid Suppressing LPS-Induced Expression of Pro-Inflammatory Cytokines and Mediators and Inhibiting the JAK/STAT Signaling Pathway 21
Enhancing the Anticancer and Anti-Inflammatory Properties of Curcumin in Combination with Quercetin, for the Prevention and Treatment of Prostate Cancer 20
Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs 17
Food System Transformation and Gut Microbiota Transition: Evidence on Advancing Obesity, Cardiovascular Diseases, and Cancers-A Narrative Review 15
Synthesis of novel N-Heterocyclic carbene-Ruthenium (II) complexes, “precious” tools with antibacterial, anticancer and antioxidant properties. 15
HIV-1 Structural Proteins or Cell-Signaling Factors? That Is the Question! 14
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 14
From HDAC to Voltage-Gated Ion Channels: What's Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer 13
Silver and Gold Complexes with NHC-Ligands Derived from Caffeine: Catalytic and Pharmacological Activity 13
The Ongoing Impact of COVID-19 on Pediatric Obesity 12
New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs 11
Antibacterial and Anti-Influenza Activities of N-Heterocyclic Carbene–Gold Complexes 7
Modulation of energetic and lipid pathways by curcumin as a potential chemopreventive strategy in human prostate cancer cells 6
Synthesis and biological evaluation of caffeine based NHC complexes. 5
Chirality influences the biological properties of novel NHC-gold and -silver complexes 5
Ru-NHC complexes with a broad spectrum of biological activities. 4
When Chirality Makes the Difference: The Case of Novel Enantiopure N-Heterocyclic Carbene–Gold and –Silver Complexes 4
Totale 4.693
Categoria #
all - tutte 34.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020187 0 0 0 0 0 0 0 60 14 19 60 34
2020/2021495 66 3 52 62 7 65 17 62 36 64 13 48
2021/2022863 15 115 10 44 96 53 11 178 13 13 119 196
2022/20231.077 139 121 51 126 131 81 27 89 145 32 97 38
2023/2024738 81 23 53 22 42 182 26 43 60 21 32 153
2024/2025772 111 188 52 129 43 64 110 75 0 0 0 0
Totale 4.693